A downtrend has been apparent in Zura Bio Limited (ZURA) lately with too much selling pressure. The stock has declined 35.6% over the past four weeks. However, given the fact that it is now in ...

Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has been given an average recommendation of “Buy” by the seven analysts that are currently covering the company, Marketbeat reports.

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia ...